These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3896215)

  • 41. Pancreatic alpha cell autoantibodies and glucagon response to arginine.
    Winter WE; Maclaren NK; Riley WJ; Unger RH; Neufeld M; Ozand PT
    Diabetes; 1984 May; 33(5):435-7. PubMed ID: 6373451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Partial recovery of insulin secretion and action after combined insulin-sulfonylurea treatment in type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral agents.
    Del Prato S; Vigili de Kreutzenberg S; Riccio A; Maifreni L; Duner E; Lisato G; Iavicoli M; Tiengo A
    Diabetologia; 1990 Nov; 33(11):688-95. PubMed ID: 2127573
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non-insulin-dependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment.
    Valensi P; Moura I; Le Magoarou M; Pariès J; Perret G; Attali JR
    Diabetes Metab; 1997 Feb; 23(1):51-7. PubMed ID: 9059766
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents.
    Irvine WJ; McCallum CJ; Gray RS; Duncan LJ
    Lancet; 1977 May; 1(8020):1025-7. PubMed ID: 67485
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relationships between diabetes duration, metabolic control and beta-cell function in a representative population of type 2 diabetic patients in Sweden.
    Clauson P; Linnarsson R; Gottsäter A; Sundkvist G; Grill V
    Diabet Med; 1994 Oct; 11(8):794-801. PubMed ID: 7851075
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
    Henry RR; Brechtel G; Griver K
    J Clin Endocrinol Metab; 1988 May; 66(5):979-86. PubMed ID: 3283164
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T-cell responses to islet antigens improves detection of autoimmune diabetes and identifies patients with more severe beta-cell lesions in phenotypic type 2 diabetes.
    Goel A; Chiu H; Felton J; Palmer JP; Brooks-Worrell B
    Diabetes; 2007 Aug; 56(8):2110-5. PubMed ID: 17473222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evidence against an immunogenetic basis for diabetes in chronic pancreatitis.
    Colman PG; Begley CG; Tait BD; Roberts-Thomson IC; Harrison LC
    Aust N Z J Med; 1987 Aug; 17(4):392-5. PubMed ID: 3325010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C-peptide response to glucagon challenge is correlated with improvement of early insulin secretion by liraglutide treatment.
    Takabe M; Matsuda T; Hirota Y; Hashimoto N; Nakamura T; Sakaguchi K; Ogawa W; Seino S
    Diabetes Res Clin Pract; 2012 Dec; 98(3):e32-5. PubMed ID: 23068961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Short-term intensive insulin therapy as a method of overcoming secondary failure of sulfonylureas in patients with type 2 diabetes (non-insulin-dependent)].
    Jedynasty K; Kasperska-Czyzykowa T; Stepień K; Nowaczyk R
    Pol Arch Med Wewn; 1998 Jun; 99(6):442-51. PubMed ID: 10085698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Beta cell function in long term NIDDM (type 2) patients and its relation to treatment.
    Snehalatha C; Ramachandran A; Mohan V; Timothy H; Viswanathan M
    Horm Metab Res; 1986 Jun; 18(6):391-4. PubMed ID: 3525362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between B-cell function and HLA antigens in patients with type 2 (non-insulin-dependent) diabetes.
    Groop L; Groop PH; Koskimies S
    Diabetologia; 1986 Nov; 29(11):757-60. PubMed ID: 3545954
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Insulin and glucagon secretion in diabetic and non-diabetic patients with circulating islet cell antibodies.
    Tiengo A; Del Prete GF; Nosadini R; Betterle C; Garotti C; Bersani G
    Diabetologia; 1977 Sep; 13(5):451-8. PubMed ID: 332569
    [TBL] [Abstract][Full Text] [Related]  

  • 55. C-peptide and insulin secretion in diabetes mellitus treated with oral hypoglycaemic agents or diet alone. A 3 years epidemiological cohort study on the Island of Falster, Denmark.
    Nielsen NV; Tronier B
    Diabetes Res; 1987 Mar; 4(3):135-9. PubMed ID: 3301161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
    Greenbaum CJ; Prigeon RL; D'Alessio DA
    Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics.
    Baron AD; Schaeffer L; Shragg P; Kolterman OG
    Diabetes; 1987 Mar; 36(3):274-83. PubMed ID: 2879757
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
    Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
    J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of insulin therapy on non-insulin-dependent diabetics with secondary oral hypoglycemic agent failure.
    Peng YS; Juang JH
    Changgeng Yi Xue Za Zhi; 1998 Sep; 21(3):271-6. PubMed ID: 9849007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of oral antidiabetic agents on plasma amylin level in patients with non-insulin-dependent diabetes mellitus (type 2).
    Zapecka-Dubno B; Czyzyk A; Dworak A; Bak MI
    Arzneimittelforschung; 1999 Apr; 49(4):330-4. PubMed ID: 10337452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.